New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
Saved in:
Main Authors: | Hans C. Hasselbalch, Richard T. Silver |
---|---|
Format: | article |
Language: | EN |
Published: |
Wolters Kluwer
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/161b2c12c78d406dba9f9777c72a3bf4 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE OUTCOME OF FATHERHOOD IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS, A SINGLE INSTITUTION EXPERIENCE
by: Elrazi Ali, et al.
Published: (2021) -
Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
by: Anagnostou T, et al.
Published: (2018) -
INFLAMMATION AND CANCER
by: Jean-François Rossi
Published: (2021) -
Cytogenetic studies for cMYC, BCL2 and BCL6 genes in neoplasm: comparison of karyotype, FISH in paraffin-embedded tissue and FISH in methanol-acetic acid-fixed cells suspensions
by: Caroline Henriques Garcia, et al.
Published: (2021) -
THE APPROACH AND DIAGNOSIS OF COOMBS NEGATIVE HEMOLYTIC ANEMIAS
by: Achille Iolascon
Published: (2021)